 Jason Tregellas
Concepts (301)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Schizophrenia | 32 | 2019 | 412 | 8.780 |
Why?
| | Brain | 46 | 2024 | 2355 | 6.880 |
Why?
| | Magnetic Resonance Imaging | 61 | 2024 | 3039 | 4.990 |
Why?
| | Brain Mapping | 37 | 2023 | 521 | 4.610 |
Why?
| | Nerve Net | 17 | 2020 | 227 | 4.370 |
Why?
| | Nicotinic Agonists | 9 | 2019 | 100 | 3.300 |
Why?
| | Nicotine | 10 | 2017 | 265 | 3.050 |
Why?
| | Schizophrenic Psychology | 9 | 2019 | 86 | 2.700 |
Why?
| | Neural Pathways | 10 | 2020 | 260 | 2.380 |
Why?
| | Sensory Gating | 5 | 2015 | 38 | 2.250 |
Why?
| | Cerebral Cortex | 14 | 2020 | 380 | 2.080 |
Why?
| | Feeding Behavior | 9 | 2023 | 572 | 2.080 |
Why?
| | Obesity | 16 | 2020 | 2505 | 2.060 |
Why?
| | Energy Intake | 9 | 2019 | 427 | 1.930 |
Why?
| | Hippocampus | 12 | 2023 | 690 | 1.900 |
Why?
| | Image Processing, Computer-Assisted | 21 | 2019 | 684 | 1.830 |
Why?
| | Overweight | 6 | 2020 | 473 | 1.800 |
Why?
| | Hunger | 7 | 2023 | 37 | 1.760 |
Why?
| | Attention | 7 | 2016 | 394 | 1.610 |
Why?
| | Epilepsies, Partial | 2 | 2021 | 29 | 1.430 |
Why?
| | Auditory Perception | 5 | 2014 | 102 | 1.400 |
Why?
| | Drug Resistant Epilepsy | 2 | 2021 | 45 | 1.390 |
Why?
| | Cues | 7 | 2022 | 301 | 1.350 |
Why?
| | Connectome | 3 | 2020 | 63 | 1.310 |
Why?
| | Food | 5 | 2022 | 160 | 1.290 |
Why?
| | Evoked Potentials, Auditory | 6 | 2015 | 167 | 1.260 |
Why?
| | Adult | 66 | 2022 | 30375 | 1.200 |
Why?
| | Acoustic Stimulation | 9 | 2016 | 306 | 1.140 |
Why?
| | Visual Perception | 7 | 2013 | 140 | 1.130 |
Why?
| | Appetite Regulation | 5 | 2019 | 26 | 1.130 |
Why?
| | Appetite | 9 | 2023 | 52 | 1.120 |
Why?
| | Epilepsy | 2 | 2021 | 278 | 1.080 |
Why?
| | Cognition | 4 | 2019 | 990 | 1.060 |
Why?
| | Psychomotor Performance | 6 | 2016 | 281 | 1.050 |
Why?
| | Cognitive Dysfunction | 3 | 2023 | 282 | 1.050 |
Why?
| | Sex Characteristics | 4 | 2023 | 636 | 1.040 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 3 | 2015 | 363 | 1.030 |
Why?
| | Executive Function | 3 | 2019 | 380 | 1.020 |
Why?
| | Male | 70 | 2023 | 55396 | 1.010 |
Why?
| | Psychotic Disorders | 3 | 2024 | 114 | 0.950 |
Why?
| | alpha7 Nicotinic Acetylcholine Receptor | 5 | 2019 | 95 | 0.940 |
Why?
| | Neurons | 6 | 2017 | 1277 | 0.940 |
Why?
| | Humans | 91 | 2024 | 114043 | 0.930 |
Why?
| | Female | 69 | 2023 | 59325 | 0.920 |
Why?
| | Prefrontal Cortex | 6 | 2013 | 263 | 0.890 |
Why?
| | Neuroimaging | 3 | 2020 | 249 | 0.850 |
Why?
| | Antipsychotic Agents | 3 | 2014 | 183 | 0.850 |
Why?
| | Reward | 6 | 2019 | 211 | 0.840 |
Why?
| | Benzylidene Compounds | 3 | 2016 | 17 | 0.820 |
Why?
| | Single-Blind Method | 8 | 2017 | 259 | 0.800 |
Why?
| | Cerebellum | 3 | 2013 | 199 | 0.790 |
Why?
| | Headache | 1 | 2023 | 132 | 0.780 |
Why?
| | Cross-Over Studies | 9 | 2016 | 439 | 0.760 |
Why?
| | Eating | 4 | 2023 | 344 | 0.760 |
Why?
| | Receptors, Nicotinic | 3 | 2013 | 273 | 0.720 |
Why?
| | Pursuit, Smooth | 4 | 2010 | 16 | 0.720 |
Why?
| | Satiation | 4 | 2019 | 22 | 0.710 |
Why?
| | Electrocorticography | 1 | 2020 | 10 | 0.700 |
Why?
| | Noise | 2 | 2012 | 66 | 0.690 |
Why?
| | Sensation Disorders | 2 | 2013 | 31 | 0.690 |
Why?
| | Cholinergic Agents | 3 | 2016 | 15 | 0.690 |
Why?
| | Neurovascular Coupling | 1 | 2019 | 7 | 0.680 |
Why?
| | Magnetoencephalography | 1 | 2020 | 99 | 0.670 |
Why?
| | Exercise | 4 | 2017 | 1642 | 0.670 |
Why?
| | Torticollis | 1 | 2019 | 12 | 0.670 |
Why?
| | Cognition Disorders | 5 | 2019 | 476 | 0.650 |
Why?
| | Pyridines | 3 | 2016 | 419 | 0.640 |
Why?
| | Middle Aged | 32 | 2019 | 26605 | 0.640 |
Why?
| | Oxygen | 10 | 2017 | 851 | 0.630 |
Why?
| | Neuronal Plasticity | 1 | 2020 | 207 | 0.620 |
Why?
| | Food Preferences | 2 | 2016 | 108 | 0.580 |
Why?
| | Reaction Time | 7 | 2015 | 373 | 0.570 |
Why?
| | Thalamus | 2 | 2009 | 74 | 0.560 |
Why?
| | Hemodynamics | 2 | 2019 | 1015 | 0.560 |
Why?
| | Memory, Short-Term | 1 | 2019 | 227 | 0.540 |
Why?
| | Parkinson Disease | 2 | 2023 | 345 | 0.540 |
Why?
| | Antiparkinson Agents | 1 | 2016 | 26 | 0.540 |
Why?
| | Electroencephalography | 5 | 2021 | 359 | 0.520 |
Why?
| | Molecular Targeted Therapy | 1 | 2019 | 347 | 0.520 |
Why?
| | Analysis of Variance | 7 | 2017 | 1218 | 0.520 |
Why?
| | Motor Activity | 2 | 2019 | 635 | 0.500 |
Why?
| | Diet, Ketogenic | 1 | 2015 | 33 | 0.500 |
Why?
| | Repetition Priming | 1 | 2015 | 8 | 0.500 |
Why?
| | Neuropsychological Tests | 10 | 2023 | 926 | 0.490 |
Why?
| | Nutrition Policy | 1 | 2015 | 54 | 0.480 |
Why?
| | Limbic System | 2 | 2015 | 43 | 0.470 |
Why?
| | Leptin | 2 | 2012 | 210 | 0.460 |
Why?
| | Clozapine | 1 | 2014 | 19 | 0.450 |
Why?
| | Body Mass Index | 6 | 2023 | 1957 | 0.450 |
Why?
| | Endophenotypes | 1 | 2013 | 16 | 0.440 |
Why?
| | Psychotropic Drugs | 1 | 2014 | 54 | 0.440 |
Why?
| | Brain Waves | 1 | 2013 | 20 | 0.430 |
Why?
| | Fingers | 1 | 2013 | 81 | 0.430 |
Why?
| | Semantics | 2 | 2013 | 89 | 0.430 |
Why?
| | Behavior Therapy | 1 | 2015 | 225 | 0.420 |
Why?
| | Frontal Lobe | 4 | 2016 | 141 | 0.410 |
Why?
| | Dronabinol | 1 | 2014 | 118 | 0.410 |
Why?
| | Efficiency | 1 | 2012 | 84 | 0.390 |
Why?
| | Psychiatric Status Rating Scales | 4 | 2017 | 481 | 0.380 |
Why?
| | Patient Compliance | 1 | 2015 | 524 | 0.370 |
Why?
| | Bipolar Disorder | 2 | 2010 | 203 | 0.370 |
Why?
| | Autistic Disorder | 3 | 2009 | 160 | 0.360 |
Why?
| | Hallucinations | 1 | 2010 | 30 | 0.350 |
Why?
| | Space Perception | 1 | 2010 | 64 | 0.340 |
Why?
| | Thinking | 2 | 2009 | 51 | 0.330 |
Why?
| | Functional Neuroimaging | 4 | 2019 | 71 | 0.330 |
Why?
| | Functional Laterality | 4 | 2013 | 196 | 0.330 |
Why?
| | Photic Stimulation | 6 | 2016 | 203 | 0.320 |
Why?
| | Reproducibility of Results | 4 | 2023 | 2764 | 0.320 |
Why?
| | Statistics as Topic | 4 | 2017 | 291 | 0.320 |
Why?
| | Urbanization | 1 | 2009 | 23 | 0.320 |
Why?
| | Nutritional Status | 1 | 2011 | 286 | 0.320 |
Why?
| | Dose-Response Relationship, Drug | 4 | 2015 | 1836 | 0.300 |
Why?
| | Body Weight | 1 | 2012 | 868 | 0.300 |
Why?
| | Case-Control Studies | 7 | 2017 | 3003 | 0.290 |
Why?
| | Young Adult | 14 | 2020 | 10444 | 0.290 |
Why?
| | Anorexia Nervosa | 3 | 2014 | 63 | 0.290 |
Why?
| | Hyperphagia | 3 | 2019 | 28 | 0.280 |
Why?
| | Child | 9 | 2021 | 18400 | 0.280 |
Why?
| | Decision Making | 1 | 2013 | 760 | 0.270 |
Why?
| | Taste | 3 | 2014 | 208 | 0.250 |
Why?
| | Computer Graphics | 2 | 2015 | 41 | 0.230 |
Why?
| | Animals | 9 | 2019 | 31565 | 0.230 |
Why?
| | Social Behavior | 1 | 2006 | 267 | 0.230 |
Why?
| | Ocular Motility Disorders | 1 | 2004 | 25 | 0.220 |
Why?
| | Biomarkers | 4 | 2019 | 3397 | 0.200 |
Why?
| | Learning | 1 | 2006 | 346 | 0.200 |
Why?
| | Child Development Disorders, Pervasive | 2 | 2013 | 58 | 0.200 |
Why?
| | Atrophy | 3 | 2023 | 152 | 0.200 |
Why?
| | Gyrus Cinguli | 3 | 2007 | 70 | 0.190 |
Why?
| | Smoking | 2 | 2007 | 1382 | 0.180 |
Why?
| | Weight Loss | 2 | 2019 | 642 | 0.180 |
Why?
| | Fasting | 4 | 2019 | 242 | 0.180 |
Why?
| | Maternal Inheritance | 1 | 2020 | 15 | 0.180 |
Why?
| | Organ Size | 3 | 2012 | 434 | 0.180 |
Why?
| | Rest | 1 | 2020 | 103 | 0.170 |
Why?
| | Neural Inhibition | 2 | 2015 | 139 | 0.170 |
Why?
| | Substance-Related Disorders | 3 | 2013 | 942 | 0.170 |
Why?
| | Parietal Lobe | 2 | 2013 | 42 | 0.160 |
Why?
| | Thinness | 2 | 2011 | 87 | 0.160 |
Why?
| | Transcranial Magnetic Stimulation | 1 | 2019 | 44 | 0.160 |
Why?
| | Seizures | 1 | 2021 | 337 | 0.160 |
Why?
| | Energy Metabolism | 2 | 2014 | 727 | 0.160 |
Why?
| | Diet, Reducing | 1 | 2019 | 76 | 0.160 |
Why?
| | Longitudinal Studies | 2 | 2023 | 2384 | 0.150 |
Why?
| | Mice | 4 | 2015 | 14841 | 0.150 |
Why?
| | Surveys and Questionnaires | 5 | 2017 | 4595 | 0.150 |
Why?
| | Drug Users | 2 | 2016 | 41 | 0.150 |
Why?
| | Absorptiometry, Photon | 2 | 2016 | 224 | 0.150 |
Why?
| | Food Analysis | 1 | 2017 | 18 | 0.150 |
Why?
| | Temporal Lobe | 2 | 2020 | 78 | 0.150 |
Why?
| | Child, Preschool | 3 | 2020 | 9114 | 0.150 |
Why?
| | Gastric Bypass | 1 | 2019 | 91 | 0.150 |
Why?
| | Adolescent | 8 | 2020 | 17800 | 0.140 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2019 | 159 | 0.140 |
Why?
| | Tobacco Use Disorder | 1 | 2019 | 234 | 0.140 |
Why?
| | Levodopa | 1 | 2016 | 23 | 0.130 |
Why?
| | Maximal Voluntary Ventilation | 1 | 2016 | 8 | 0.130 |
Why?
| | Social Control, Informal | 2 | 2013 | 18 | 0.130 |
Why?
| | Cerebrovascular Circulation | 2 | 2009 | 219 | 0.130 |
Why?
| | Basal Metabolism | 1 | 2016 | 46 | 0.130 |
Why?
| | Sensitivity and Specificity | 1 | 2020 | 1690 | 0.130 |
Why?
| | Cohort Studies | 3 | 2020 | 4883 | 0.130 |
Why?
| | Autism Spectrum Disorder | 1 | 2020 | 322 | 0.130 |
Why?
| | Dietary Fiber | 1 | 2016 | 40 | 0.130 |
Why?
| | Aversive Therapy | 1 | 2015 | 3 | 0.130 |
Why?
| | Lost to Follow-Up | 1 | 2015 | 20 | 0.120 |
Why?
| | Treatment Outcome | 2 | 2021 | 9049 | 0.120 |
Why?
| | Ketones | 1 | 2015 | 44 | 0.120 |
Why?
| | Hormones | 1 | 2016 | 132 | 0.120 |
Why?
| | Choice Behavior | 1 | 2016 | 150 | 0.120 |
Why?
| | Time Factors | 3 | 2015 | 6077 | 0.120 |
Why?
| | Patch-Clamp Techniques | 1 | 2015 | 239 | 0.120 |
Why?
| | Dietary Proteins | 1 | 2016 | 121 | 0.120 |
Why?
| | Administration, Cutaneous | 1 | 2014 | 117 | 0.120 |
Why?
| | Sweetening Agents | 1 | 2014 | 37 | 0.120 |
Why?
| | Computer Simulation | 2 | 2019 | 873 | 0.110 |
Why?
| | CA3 Region, Hippocampal | 1 | 2014 | 4 | 0.110 |
Why?
| | Signal-To-Noise Ratio | 1 | 2014 | 56 | 0.110 |
Why?
| | Gamma Rhythm | 1 | 2013 | 4 | 0.110 |
Why?
| | Mice, Inbred DBA | 1 | 2014 | 174 | 0.110 |
Why?
| | Regression Analysis | 4 | 2019 | 945 | 0.110 |
Why?
| | Blood Glucose | 2 | 2019 | 1827 | 0.110 |
Why?
| | Heart Rate | 1 | 2017 | 710 | 0.110 |
Why?
| | Psycholinguistics | 1 | 2013 | 19 | 0.110 |
Why?
| | Aged | 3 | 2019 | 18969 | 0.110 |
Why?
| | Diabetes, Gestational | 1 | 2017 | 281 | 0.110 |
Why?
| | Mice, Inbred C3H | 1 | 2013 | 242 | 0.110 |
Why?
| | Symptom Assessment | 1 | 2014 | 119 | 0.110 |
Why?
| | Weight Gain | 2 | 2013 | 453 | 0.100 |
Why?
| | Satiety Response | 1 | 2012 | 8 | 0.100 |
Why?
| | Insulin | 2 | 2019 | 2080 | 0.100 |
Why?
| | Cross-Sectional Studies | 1 | 2023 | 4402 | 0.100 |
Why?
| | Drug Discovery | 1 | 2013 | 123 | 0.100 |
Why?
| | Drug Interactions | 1 | 2014 | 337 | 0.100 |
Why?
| | Body Composition | 1 | 2016 | 590 | 0.100 |
Why?
| | Models, Animal | 1 | 2014 | 340 | 0.100 |
Why?
| | Task Performance and Analysis | 1 | 2013 | 160 | 0.100 |
Why?
| | Parents | 2 | 2012 | 1181 | 0.100 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2017 | 453 | 0.100 |
Why?
| | Health Behavior | 1 | 2017 | 701 | 0.090 |
Why?
| | Conduct Disorder | 1 | 2013 | 193 | 0.090 |
Why?
| | Pregnancy | 2 | 2020 | 5499 | 0.090 |
Why?
| | Fornix, Brain | 1 | 2011 | 6 | 0.090 |
Why?
| | Marijuana Abuse | 1 | 2014 | 211 | 0.090 |
Why?
| | Algorithms | 2 | 2019 | 1469 | 0.090 |
Why?
| | Sensation | 1 | 2011 | 44 | 0.090 |
Why?
| | Nerve Fibers, Myelinated | 1 | 2011 | 41 | 0.090 |
Why?
| | Subliminal Stimulation | 1 | 2010 | 2 | 0.090 |
Why?
| | Exercise Test | 1 | 2013 | 547 | 0.090 |
Why?
| | Speech Perception | 1 | 2012 | 73 | 0.090 |
Why?
| | Blood Pressure | 1 | 2017 | 1531 | 0.090 |
Why?
| | Models, Statistical | 1 | 2014 | 595 | 0.090 |
Why?
| | Eye Movements | 1 | 2010 | 51 | 0.090 |
Why?
| | Facial Expression | 1 | 2010 | 60 | 0.090 |
Why?
| | Diet | 2 | 2017 | 1080 | 0.080 |
Why?
| | Colorado | 2 | 2019 | 4090 | 0.080 |
Why?
| | Self-Injurious Behavior | 1 | 2011 | 114 | 0.080 |
Why?
| | Outpatients | 1 | 2012 | 325 | 0.080 |
Why?
| | Corpus Striatum | 1 | 2010 | 126 | 0.080 |
Why?
| | Fragile X Syndrome | 1 | 2009 | 65 | 0.080 |
Why?
| | Artifacts | 2 | 2007 | 114 | 0.080 |
Why?
| | Family | 1 | 2012 | 589 | 0.080 |
Why?
| | Mice, Transgenic | 1 | 2013 | 1947 | 0.080 |
Why?
| | Reference Values | 2 | 2008 | 739 | 0.080 |
Why?
| | Arousal | 1 | 2009 | 152 | 0.070 |
Why?
| | Genotype | 2 | 2010 | 1757 | 0.070 |
Why?
| | Double-Blind Method | 2 | 2009 | 1656 | 0.070 |
Why?
| | Dominance, Cerebral | 1 | 2007 | 49 | 0.070 |
Why?
| | Prospective Studies | 2 | 2017 | 6195 | 0.070 |
Why?
| | Visual Fields | 2 | 2005 | 77 | 0.070 |
Why?
| | Rats | 1 | 2015 | 4913 | 0.070 |
Why?
| | Aggression | 1 | 2009 | 181 | 0.070 |
Why?
| | Nerve Fibers | 1 | 2007 | 86 | 0.070 |
Why?
| | Postprandial Period | 2 | 2019 | 87 | 0.070 |
Why?
| | Communication Disorders | 1 | 2006 | 7 | 0.070 |
Why?
| | Auditory Cortex | 1 | 2007 | 38 | 0.070 |
Why?
| | Stereotyped Behavior | 1 | 2006 | 19 | 0.070 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 2 | 2007 | 230 | 0.070 |
Why?
| | Hypothalamus | 1 | 2007 | 147 | 0.070 |
Why?
| | Intelligence | 1 | 2006 | 130 | 0.060 |
Why?
| | Disease Models, Animal | 1 | 2015 | 3498 | 0.060 |
Why?
| | Ganglionic Stimulants | 1 | 2005 | 10 | 0.060 |
Why?
| | Emotions | 1 | 2010 | 474 | 0.060 |
Why?
| | Judgment | 1 | 2006 | 55 | 0.060 |
Why?
| | Visual Cortex | 1 | 2005 | 41 | 0.060 |
Why?
| | Pain | 1 | 2010 | 701 | 0.060 |
Why?
| | Visual Pathways | 1 | 2005 | 44 | 0.060 |
Why?
| | Amygdala | 2 | 2016 | 171 | 0.060 |
Why?
| | Breakfast | 2 | 2016 | 14 | 0.060 |
Why?
| | Area Under Curve | 1 | 2005 | 273 | 0.060 |
Why?
| | Feasibility Studies | 1 | 2007 | 735 | 0.060 |
Why?
| | Retrospective Studies | 1 | 2020 | 12521 | 0.060 |
Why?
| | Risk Factors | 2 | 2017 | 8614 | 0.050 |
Why?
| | Head | 1 | 2004 | 85 | 0.050 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2010 | 1880 | 0.050 |
Why?
| | Promoter Regions, Genetic | 1 | 2007 | 1131 | 0.050 |
Why?
| | Basal Ganglia | 1 | 2023 | 44 | 0.050 |
Why?
| | Movement | 1 | 2004 | 242 | 0.050 |
Why?
| | Insulin Resistance | 2 | 2019 | 1072 | 0.050 |
Why?
| | Interview, Psychological | 2 | 2013 | 85 | 0.040 |
Why?
| | Image Interpretation, Computer-Assisted | 2 | 2012 | 224 | 0.040 |
Why?
| | Peptide YY | 1 | 2019 | 13 | 0.040 |
Why?
| | Ghrelin | 1 | 2019 | 33 | 0.040 |
Why?
| | Statistics, Nonparametric | 1 | 2019 | 384 | 0.040 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2019 | 100 | 0.040 |
Why?
| | Models, Neurological | 1 | 2019 | 212 | 0.040 |
Why?
| | Language | 1 | 2019 | 263 | 0.030 |
Why?
| | Lunch | 1 | 2016 | 7 | 0.030 |
Why?
| | Machine Learning | 1 | 2019 | 315 | 0.030 |
Why?
| | Homeostasis | 1 | 2019 | 570 | 0.030 |
Why?
| | Taste Perception | 1 | 2014 | 21 | 0.030 |
Why?
| | Mothers | 1 | 2019 | 650 | 0.030 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2014 | 131 | 0.030 |
Why?
| | Socioeconomic Factors | 1 | 2017 | 1080 | 0.030 |
Why?
| | Pleasure | 1 | 2013 | 18 | 0.030 |
Why?
| | Principal Component Analysis | 1 | 2013 | 177 | 0.030 |
Why?
| | Sucrose | 1 | 2012 | 92 | 0.020 |
Why?
| | Conditioning, Operant | 1 | 2012 | 97 | 0.020 |
Why?
| | Phenotype | 1 | 2019 | 2784 | 0.020 |
Why?
| | Anisotropy | 1 | 2011 | 61 | 0.020 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2011 | 83 | 0.020 |
Why?
| | Nerve Fibers, Unmyelinated | 1 | 2008 | 9 | 0.020 |
Why?
| | Temperance | 1 | 2008 | 13 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2017 | 4392 | 0.020 |
Why?
| | Amphetamine-Related Disorders | 1 | 2008 | 29 | 0.020 |
Why?
| | Lod Score | 1 | 2007 | 65 | 0.020 |
Why?
| | Cocaine-Related Disorders | 1 | 2008 | 108 | 0.020 |
Why?
| | Alcohol-Related Disorders | 1 | 2008 | 113 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2011 | 1791 | 0.020 |
Why?
| | Imaging, Three-Dimensional | 1 | 2008 | 511 | 0.020 |
Why?
| | Chewing Gum | 1 | 2004 | 8 | 0.010 |
Why?
| | Verbal Behavior | 1 | 2004 | 44 | 0.010 |
Why?
| | Polymorphism, Genetic | 1 | 2007 | 610 | 0.010 |
Why?
| | Genetic Linkage | 1 | 2005 | 294 | 0.010 |
Why?
| | Genetic Markers | 1 | 2005 | 320 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2012 | 2090 | 0.010 |
Why?
| | Early Diagnosis | 1 | 2005 | 217 | 0.010 |
Why?
| | Gene Frequency | 1 | 2005 | 476 | 0.010 |
Why?
| | Administration, Oral | 1 | 2005 | 725 | 0.010 |
Why?
| | Fourier Analysis | 1 | 2002 | 39 | 0.010 |
Why?
|
|
Tregellas's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|